Pursuant to its Comprehensive Economic and Trade Agreement commitments, Canada recently enacted patent term adjustment provisions which can extend the 20-year period of patent protection for up to an additional two years.
The “Certificate of Supplementary Protection” regime permits patentees to seek an additional two years of protection for patents that pertain to a medicinal ingredient, or combination of medicinal ingredients, contained in a drug for which the authorization for sale is the first authorization for sale issued with respect to the medicinal ingredient or the combination of medicinal ingredients.
The period of extension is computed by reference to the time taken for approval by the Minister of Health under the Food and Drug Regulations. Importantly, the two-year extension may be reduced where the Minister of Health is of the opinion that a person’s failure to act resulted in a period of unjustified delay in the process of obtaining the authorization for sale.
Few certificates of supplementary protection have been granted in Canada and there has been no consideration of what circumstances, if any, would constitute a failure to act sufficient to reduce the two-year maximum.
The U.S. Court of Appeals for the Federal Circuit recently considered a potentially analogous issue. In Supernus Pharmaceuticals v Iancu, the Court found that the United States Patent and Trademark Office exceeded its statutory authority by subtracting days from Supernus’ patent term adjustment where the company had not failed to make reasonable efforts to prosecute its application. The test applied by the Court was whether the applicant in the period of its purported delay could have taken any steps. If not, its actions were not unreasonable.
While the decision considers the use of patent term adjustment to compensate for delays in the patent office, and not regulatory approval, it may nonetheless provide insight into the considerations the Minister may undertake when considering a patent extension in Canada.
Authors
Insights
-
Intellectual Property Litigation
Fallout from Trade Secret Theft in Taiwan
As reported by Reuters, three former employees of Taiwan Semiconductor Manufacturing Company ("TSMC") were charged with violating security law and other offences in Taiwan. The prosecutors have… -
Intellectual Property Litigation
U.S Appeals Court Sends $81 Million Award Against Boeing Flying Back In!
As reported by Reuters, the 9th US Circuit Court of Appeals has reinstated an $81 million award against Boeing, in a suit brought by Zunum Aero, an aircraft startup, accusing Boeing of stealing trade… -
Intellectual Property Litigation
Carrot Puff Copycat: Copyright Infringed in Federal Court of Australia Case
As reported by Mason Hayes & Curran, the Federal Court of Australia has reportedly found the supermarket chain, Aldi, liable for copyright infringement regarding illustrations used on the… -
Intellectual Property Litigation
Carnegie Hall Takes Trademark Center Stage in Legal Battle
Carnegie Hall has reportedly commenced an action against Carnegie Diner and Café for trademark infringement.In its complaint filed with the United States District Court, Southern District of New York… -
Intellectual Property Litigation
Federal Court of Appeal Reiterates Permissive Approach to Granting Leave to Amend Defective Pleadings
In Bell Canada et al. v. Millennium Funding, Inc. et al., 2025 FCA 153, Bell Canada and Bell Aliant (collectively, “Bell”) appealed an order granting the Respondents’ (collectively, “Millenium… -
Intellectual Property Litigation
Under the Radar, Over the Counter: Goyard's Quiet Battle Against Fake Luxury
Goyard, the Parisian brand established in 1853 and still privately owned, has reportedly faced a surge in counterfeit bags flooding the market. The company refrains from advertising, avoids e-commerce…
Featured Work
-
Mergers and Acquisitions
Dayforce to be taken private by Thoma Bravo for US$12.3 billion
Goodmans LLP is advising Dayforce, Inc. as Canadian counsel in connection with its definitive agreement to be taken private by Thoma Bravo in an all-cash transaction with an enterprise value of… -
Mergers and Acquisitions
RF Capital Group to be acquired by iA Financial Corporation in C$597 million all-cash transaction
Goodmans LLP is advising RF Capital Group in connection with its sale to iA Financial Corporation, a Quebec City-based insurance and wealth management company, in an all-cash transaction valued at… -
Mergers and Acquisitions
Apotex acquires CanPrev
Goodmans LLP acted for Apotex Inc. in connection with its acquisition of CanPrev, a leading Canadian provider of vitamins, supplements, and other natural health products… -
Mergers and Acquisitions
Apotex acquires Searchlight Pharma Inc.
Goodmans LLP advised Apotex Inc. in connection with its acquisition of Searchlight Pharma Inc… -
Mergers and Acquisitions
FASHIONPHILE acquires Two Authenticators Business
Goodmans LLP acted for FASHIONPHILE, LLC in connection with its purchase of the assets of Two Authenticators Inc… -
Mergers and Acquisitions
Minute Media acquires STN Video
Goodmans LLP acted for Minute Media, a leading global technology and sports content company, in connection with its acquisition of STN Video, a North American industry leader in sports content…
News & Events
-
Intellectual Property Litigation
LMG Life Sciences Honours Goodmans Intellectual Property Litigation Group
Goodmans LLP Intellectual Property Litigation Group is recognized as Highly Recommended in Patent Litigation (Generic) in the 2025 edition of LMG Life Sciences for the third year in a… -
Aging and Healthcare
Goodmans Honoured Again with Top-Tier Recognition from Chambers and Partners
We are delighted to announce Goodmans LLP continues to receive top-tier recognition from Chambers and Partners in the Chambers Canada 2026 Guide.Recognition from Chambers and Partners is based on… -
Intellectual Property Litigation
Goodmans Once Again Honoured at LMG Life Sciences Americas Awards 2025
We are proud to share the Goodmans Intellectual Property Litigation team has been awarded at the LMG Life Sciences Americas Awards 2025 for the second year in a row!Patent Impact Case of the Year…